Source: MarketScreener

Valeritas: Zealand Pharma completes the acquisition of Valeritas

(marketscreener.com) Company announcement - No. 15 / 2020 Zealand Pharma completes the acquisition of Valeritas Zealand Pharma has acquired Valeritas Holdings, Inc. , a U.S. based commercial-stage company for a cash purchase price of $23 million The marketed V-Go® wearable insulin delivery device, 110 employees, all supporting systems,...https://www.marketscreener.com/ZEALAND-PHARMA-A-S-6970764/news/Zealand-Pharma-completes-the-acquisition-of-Valeritas-30295824/?utm_medium=RSS&utm_content=20200402

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
John Timberlake's photo - President & CEO of Valeritas

President & CEO

John Timberlake

CEO Approval Rating

85/100

Read more